Cyclosporine C2 Monitoring for the Treatment of Frequently Relapsing Nephrotic Syndrome in Children
Kazumoto Iijima(Kobe Children's Hospital), Norishige Yoshikawa(Takatsuki General Hospital), Yoko Ohwada(Dokkyo Medical University), Ryojiro Tanaka(Kobe Children's Hospital), Koichi Nakanishi(University of the Ryukyus), Shuichi Ito(Yokohama City University), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Mari S. Oba(Yokohama City University), Koichi Kamei(National Center For Child Health and Development), Yasuo Ohashi(Chuo University), Michio Nagata(Mie Chuo Medical Center), Masataka Honda(Rikkyo University), Nahoko Yata, Kandai Nozu(Kobe Children's Hospital), Mayumi Sako(National Center For Child Health and Development), Hidefumi Nakamura(National Center For Child Health and Development)
Cited by 32
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267